Alzheimer Europe’s December 2021 newsletter brings you the latest news on developments in the dementia field, across Europe and beyond.


Summaries of a few of our top stories appear below.


Our monthly newsletter reaches around 11,000 people and we are always happy to receive feedback, or suggestions regarding news items to share in future issues.


7 December: European Group of Governmental Experts meets online

The European Group of Governmental Experts on Dementia held its final meeting of 2021, exchanging information and knowledge about the latest developments in dementia policy and practice. 19 countries were represented, as well as the European Commission and the WHO.

17 December: EMA rejects marketing authorisation application for aducanumab

On 17 December 2021, the European Medicines Agency (EMA), in a decision closely watched by the European dementia community, decided not to authorise aducanumab for the treatment of mild cognitive impairment due to Alzheimer’s disease and mild Alzheimer’s dementia.

17 December: Our conference videos are now available on demand

We are pleased to announce that videos of the 31st Alzheimer Europe Conference sessions (plenary, parallel and symposia) are now available on demand. If you were not previously registered for the event, but would like to gain access to these videos, you can still register for a reduced fee.

22 December: EU-FINGERS project launches its website

The EU-FINGERS consortium is proud to announce the official launch of its website. EU-FINGERS is, by means of a precision medicine approach, working on the topic of the prevention of Alzheimer’s disease and builds on the work of similar existing European studies.